Skip to main content
Erschienen in: American Journal of Clinical Dermatology 4/2023

01.02.2023 | Current Opinion

Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology

verfasst von: Ashley M. Snyder, Suephy C. Chen, Mary-Margaret Chren, Laura K. Ferris, LaVar D. Edwards, Robert A. Swerlick, Nicholas D. Flint, Amy M. Cizik, Rachel Hess, Jacob Kean, Aaron M. Secrest, for the Dermatology PRO Consortium

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

With more disease- and symptom-specific measures available and research pointing to increased usefulness, patient-reported outcome measures (PROMs) can be routinely used in clinical care. PROMs increase efficiency in healthcare, improve the clinician–patient relationship, and increase patient satisfaction with their care. PROMs can be administered before, during, and after clinic visits using paper-and-pencil, mobile phones, tablets, and computers. Herein, we combine available literature with expert views to discuss overcoming barriers and helping dermatologists incorporate PROMs into routine patient-centered care. We believe dermatology patients will benefit from broader PROM implementation and routine clinical use. However, a few major barriers exist: (1) cost to implement the technology, (2) selecting the right PROMs for each disease, and (3) helping both patients and clinicians understand how PROMs add to and complement their current clinical experience. We provide recommendations to assist dermatologists when considering whether to implement PROMs in their practices.
Literatur
1.
Zurück zum Zitat Institute of Medicine (IOM). Crossing the quality chasm: a new health system for the 21st century. Washington, DC: The National Academies Press; 2001. Institute of Medicine (IOM). Crossing the quality chasm: a new health system for the 21st century. Washington, DC: The National Academies Press; 2001.
2.
Zurück zum Zitat Barry MJ, Edgman-Levitan S. Shared decision making–pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–1.PubMed Barry MJ, Edgman-Levitan S. Shared decision making–pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–1.PubMed
3.
Zurück zum Zitat Magin PJ, Adams J, Heading GS, Pond CD. Patients with skin disease and their relationships with their doctors: a qualitative study of patients with acne, psoriasis and eczema. Med J Aust. 2009;190(2):62–4.PubMed Magin PJ, Adams J, Heading GS, Pond CD. Patients with skin disease and their relationships with their doctors: a qualitative study of patients with acne, psoriasis and eczema. Med J Aust. 2009;190(2):62–4.PubMed
4.
Zurück zum Zitat Magin PJ, Pond CD, Smith WT, Watson AB, Goode SM. Correlation and agreement of self-assessed and objective skin disease severity in a cross-sectional study of patients with acne, psoriasis, and atopic eczema. Int J Dermatol. 2011;50(12):1486–90.PubMed Magin PJ, Pond CD, Smith WT, Watson AB, Goode SM. Correlation and agreement of self-assessed and objective skin disease severity in a cross-sectional study of patients with acne, psoriasis, and atopic eczema. Int J Dermatol. 2011;50(12):1486–90.PubMed
5.
Zurück zum Zitat Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–8.PubMedPubMedCentral Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–8.PubMedPubMedCentral
6.
Zurück zum Zitat Baumhauer JF. Patient-reported outcomes—are they living up to their potential? N Engl J Med. 2017;377(1):6–9.PubMed Baumhauer JF. Patient-reported outcomes—are they living up to their potential? N Engl J Med. 2017;377(1):6–9.PubMed
7.
Zurück zum Zitat Reddy A, Fihn SD, Liao JM. The VA MISSION Act—creating a center for innovation within the VA. N Engl J Med. 2019;380(17):1592–4.PubMed Reddy A, Fihn SD, Liao JM. The VA MISSION Act—creating a center for innovation within the VA. N Engl J Med. 2019;380(17):1592–4.PubMed
8.
Zurück zum Zitat Kocher KE, Ayanian JZ. Flipping the script—a patient-centered approach to fixing acute care. N Engl J Med. 2016;375(10):915–7.PubMed Kocher KE, Ayanian JZ. Flipping the script—a patient-centered approach to fixing acute care. N Engl J Med. 2016;375(10):915–7.PubMed
9.
Zurück zum Zitat Warraich HJ, Meier DE. Serious-illness care 2.0—meeting the needs of patients with heart failure. N Engl J Med. 2019;380(26):2492–4. Warraich HJ, Meier DE. Serious-illness care 2.0—meeting the needs of patients with heart failure. N Engl J Med. 2019;380(26):2492–4.
10.
Zurück zum Zitat Saloner B, Stoller KB, Alexander GC. Moving addiction care to the mainstream—improving the quality of buprenorphine treatment. N Engl J Med. 2018;379(1):4–6.PubMedPubMedCentral Saloner B, Stoller KB, Alexander GC. Moving addiction care to the mainstream—improving the quality of buprenorphine treatment. N Engl J Med. 2018;379(1):4–6.PubMedPubMedCentral
11.
Zurück zum Zitat Calvert MJ, O’Connor DJ, Basch EM. Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes. Nat Rev Drug Discov. 2019;18(10):731–2.PubMed Calvert MJ, O’Connor DJ, Basch EM. Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes. Nat Rev Drug Discov. 2019;18(10):731–2.PubMed
12.
Zurück zum Zitat Blauvelt A, Wu JJ, Armstrong A, Menter A, Liu C, Jacobson A. Importance of complete skin clearance in psoriasis as a treatment goal: implications for patient-reported outcomes. J Drugs Dermatol. 2020;19(5):487–92.PubMed Blauvelt A, Wu JJ, Armstrong A, Menter A, Liu C, Jacobson A. Importance of complete skin clearance in psoriasis as a treatment goal: implications for patient-reported outcomes. J Drugs Dermatol. 2020;19(5):487–92.PubMed
13.
Zurück zum Zitat Secrest AM, Hopkins ZH, Frost ZE, Taliercio VL, Edwards LD, Biber JE, et al. Quality of life assessed using Skindex-16 scores among patients with acne receiving isotretinoin treatment. JAMA Dermatol. 2020;8: e202330. Secrest AM, Hopkins ZH, Frost ZE, Taliercio VL, Edwards LD, Biber JE, et al. Quality of life assessed using Skindex-16 scores among patients with acne receiving isotretinoin treatment. JAMA Dermatol. 2020;8: e202330.
15.
Zurück zum Zitat Greenhalgh J, Gooding K, Gibbons E, Dalkin S, Wright J, Valderas J, et al. How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis. J Patient Rep Outcomes. 2018;2:42.PubMedPubMedCentral Greenhalgh J, Gooding K, Gibbons E, Dalkin S, Wright J, Valderas J, et al. How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis. J Patient Rep Outcomes. 2018;2:42.PubMedPubMedCentral
16.
Zurück zum Zitat Lizée T, Basch E, Trémolières P, Voog E, Domont J, Peyraga G, et al. Cost-effectiveness of web-based patient-reported outcome surveillance in patients with lung cancer. J Thorac Oncol. 2019;14(6):1012–20.PubMed Lizée T, Basch E, Trémolières P, Voog E, Domont J, Peyraga G, et al. Cost-effectiveness of web-based patient-reported outcome surveillance in patients with lung cancer. J Thorac Oncol. 2019;14(6):1012–20.PubMed
17.
Zurück zum Zitat Nixon NA, Spackman E, Clement F, Verma S, Manns B. Cost-effectiveness of symptom monitoring with patient-reported outcomes during routine cancer treatment. J Cancer Policy. 2018;15:32–6. Nixon NA, Spackman E, Clement F, Verma S, Manns B. Cost-effectiveness of symptom monitoring with patient-reported outcomes during routine cancer treatment. J Cancer Policy. 2018;15:32–6.
18.
Zurück zum Zitat Chren M-M. Measurement of vital signs for skin diseases. J Investig Dermatol. 2005;125(4):viii–ix. Chren M-M. Measurement of vital signs for skin diseases. J Investig Dermatol. 2005;125(4):viii–ix.
19.
Zurück zum Zitat Secrest AM, Chren MM. Incorporating patient-reported outcomes as a vital sign for dermatologic clinical care and clinical investigations. J Investig Dermatol. 2022;142(6):1529–1532. Secrest AM, Chren MM. Incorporating patient-reported outcomes as a vital sign for dermatologic clinical care and clinical investigations. J Investig Dermatol. 2022;142(6):1529–1532.
20.
Zurück zum Zitat Finlay AY, Salek MS, Abeni D, Tomas-Aragones L, van Cranenburgh OD, Evers AW, et al. Why quality of life measurement is important in dermatology clinical practice: an expert-based opinion statement by the EADV Task Force on Quality of Life. J Eur Acad Dermatol Venereol. 2017;31(3):424–31.PubMed Finlay AY, Salek MS, Abeni D, Tomas-Aragones L, van Cranenburgh OD, Evers AW, et al. Why quality of life measurement is important in dermatology clinical practice: an expert-based opinion statement by the EADV Task Force on Quality of Life. J Eur Acad Dermatol Venereol. 2017;31(3):424–31.PubMed
21.
Zurück zum Zitat Chren M-M. Understanding research about quality of life and other health outcomes. J Cutan Med Surg. 1999;3(6):312–6.PubMed Chren M-M. Understanding research about quality of life and other health outcomes. J Cutan Med Surg. 1999;3(6):312–6.PubMed
22.
Zurück zum Zitat Kroenke K, Monahan PO, Kean J. Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice. J Clin Epidemiol. 2015;68(9):1085–92.PubMedPubMedCentral Kroenke K, Monahan PO, Kean J. Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice. J Clin Epidemiol. 2015;68(9):1085–92.PubMedPubMedCentral
26.
Zurück zum Zitat Silverberg JI, Hinami K, Trick WE, Cella D. Itch in the general internal medicine setting: a cross-sectional study of prevalence and quality-of-life effects. Am J Clin Dermatol. 2016;17(6):681–90.PubMedPubMedCentral Silverberg JI, Hinami K, Trick WE, Cella D. Itch in the general internal medicine setting: a cross-sectional study of prevalence and quality-of-life effects. Am J Clin Dermatol. 2016;17(6):681–90.PubMedPubMedCentral
29.
Zurück zum Zitat Rothrock NE, Kaat AJ, Vrahas MS, O’Toole RV, Buono SK, Morrison S, et al. Validation of PROMIS physical function instruments in patients with an orthopaedic trauma to a lower extremity. J Orthop Trauma. 2019;33(8):377–83.PubMed Rothrock NE, Kaat AJ, Vrahas MS, O’Toole RV, Buono SK, Morrison S, et al. Validation of PROMIS physical function instruments in patients with an orthopaedic trauma to a lower extremity. J Orthop Trauma. 2019;33(8):377–83.PubMed
30.
Zurück zum Zitat Hung M, Stuart AR, Higgins TF, Saltzman CL, Kubiak EN. Computerized adaptive testing using the PROMIS Physical Function Item Bank Reduces test burden with less ceiling effects compared with the short Musculoskeletal Function Assessment in orthopaedic trauma patients. J Orthop Trauma. 2014;28(8):439–43.PubMed Hung M, Stuart AR, Higgins TF, Saltzman CL, Kubiak EN. Computerized adaptive testing using the PROMIS Physical Function Item Bank Reduces test burden with less ceiling effects compared with the short Musculoskeletal Function Assessment in orthopaedic trauma patients. J Orthop Trauma. 2014;28(8):439–43.PubMed
31.
Zurück zum Zitat Nolte S, Coon C, Hudgens S, Verdam MGE. Psychometric evaluation of the PROMIS® Depression Item Bank: an illustration of classical test theory methods. J Patient Rep Outcomes. 2019;3(1):46. Nolte S, Coon C, Hudgens S, Verdam MGE. Psychometric evaluation of the PROMIS® Depression Item Bank: an illustration of classical test theory methods. J Patient Rep Outcomes. 2019;3(1):46.
32.
Zurück zum Zitat Pilkonis PA, Yu L, Dodds NE, Johnston KL, Maihoefer CC, Lawrence SM. Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res. 2014;56:112–9.PubMedPubMedCentral Pilkonis PA, Yu L, Dodds NE, Johnston KL, Maihoefer CC, Lawrence SM. Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res. 2014;56:112–9.PubMedPubMedCentral
33.
Zurück zum Zitat Chren M-M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Investig Dermatol. 1996;107(5):707–13.PubMed Chren M-M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Investig Dermatol. 1996;107(5):707–13.PubMed
34.
Zurück zum Zitat Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol. 2004;4:8.PubMedPubMedCentral Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol. 2004;4:8.PubMedPubMedCentral
35.
Zurück zum Zitat He Z, Lu C, Basra MK, Ou A, Yan Y, Li L. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27(1):109–15.PubMed He Z, Lu C, Basra MK, Ou A, Yan Y, Li L. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27(1):109–15.PubMed
36.
Zurück zum Zitat Shikiar R, Bresnahan BW, Stone SP, Thompson C, Koo J, Revicki DA. Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes. 2003;1(1):53.PubMedPubMedCentral Shikiar R, Bresnahan BW, Stone SP, Thompson C, Koo J, Revicki DA. Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes. 2003;1(1):53.PubMedPubMedCentral
40.
Zurück zum Zitat Rai SK, Yazdany J, Fortin PR, Aviña-Zubieta JA. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Arthritis Res Ther. 2015;17(1):143.PubMedPubMedCentral Rai SK, Yazdany J, Fortin PR, Aviña-Zubieta JA. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Arthritis Res Ther. 2015;17(1):143.PubMedPubMedCentral
41.
Zurück zum Zitat Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Investig Dermatol. 2007;127(6):1351–7.PubMed Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Investig Dermatol. 2007;127(6):1351–7.PubMed
42.
Zurück zum Zitat Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92.PubMed Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92.PubMed
43.
Zurück zum Zitat Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47(1):81–7.PubMed Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47(1):81–7.PubMed
44.
Zurück zum Zitat Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology. 2015;230(1):27–33.PubMed Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology. 2015;230(1):27–33.PubMed
45.
Zurück zum Zitat Gaufin M, Hess R, Hopkins ZH, Biber JE, Secrest AM. Practical screening for depression in dermatology: using technology to improve care. Br J Dermatol. 2020;182(3):786–7.PubMed Gaufin M, Hess R, Hopkins ZH, Biber JE, Secrest AM. Practical screening for depression in dermatology: using technology to improve care. Br J Dermatol. 2020;182(3):786–7.PubMed
47.
Zurück zum Zitat Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health. 1980;34(4):281–6.PubMedPubMedCentral Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health. 1980;34(4):281–6.PubMedPubMedCentral
48.
Zurück zum Zitat Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.PubMed Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.PubMed
50.
Zurück zum Zitat Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105–10.PubMed Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105–10.PubMed
51.
Zurück zum Zitat Taliercio VL, Snyder AM, Biggs AM, Kean J, Hess R, Duffin KC, et al. Clinicians' perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study. Qual Life Res. 2022;31(6):1719–1725. Taliercio VL, Snyder AM, Biggs AM, Kean J, Hess R, Duffin KC, et al. Clinicians' perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study. Qual Life Res. 2022;31(6):1719–1725.
53.
Zurück zum Zitat Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. JAMA Dermatol. 2004;140(12):1513–9. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. JAMA Dermatol. 2004;140(12):1513–9.
54.
Zurück zum Zitat Rolstad S, Adler J, Rydén A. Response burden and questionnaire length: is shorter better? A review and meta-analysis. Value Health. 2011;14(8):1101–8.PubMed Rolstad S, Adler J, Rydén A. Response burden and questionnaire length: is shorter better? A review and meta-analysis. Value Health. 2011;14(8):1101–8.PubMed
55.
Zurück zum Zitat Hernar I, Graue M, Richards D, Strandberg RB, Nilsen RM, Tell GS, et al. Electronic capturing of patient-reported outcome measures on a touchscreen computer in clinical diabetes practice (the DiaPROM trial): a feasibility study. Pilot Feasib Stud. 2019;5:29. Hernar I, Graue M, Richards D, Strandberg RB, Nilsen RM, Tell GS, et al. Electronic capturing of patient-reported outcome measures on a touchscreen computer in clinical diabetes practice (the DiaPROM trial): a feasibility study. Pilot Feasib Stud. 2019;5:29.
56.
Zurück zum Zitat Swerlick RA, Zhang C, Patel A, Chren MM, Chen S. The Skindex-Mini: a streamlined quality of life measurement tool suitable for routine use in clinic. J Am Acad Dermatol. 2021;85(2):510–2.PubMed Swerlick RA, Zhang C, Patel A, Chren MM, Chen S. The Skindex-Mini: a streamlined quality of life measurement tool suitable for routine use in clinic. J Am Acad Dermatol. 2021;85(2):510–2.PubMed
57.
Zurück zum Zitat Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, et al. How data can deliver for dermatology. J Am Acad Dermatol. 2018;79(2):400–2.PubMedPubMedCentral Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, et al. How data can deliver for dermatology. J Am Acad Dermatol. 2018;79(2):400–2.PubMedPubMedCentral
58.
Zurück zum Zitat Secrest AM, Chren M-M, Hopkins ZH, Chen SC, Ferris LK, Hess R. Benefits to patient care of electronically capturing patient-reported outcomes in dermatology. Br J Dermatol. 2019;181(4):826–7.PubMed Secrest AM, Chren M-M, Hopkins ZH, Chen SC, Ferris LK, Hess R. Benefits to patient care of electronically capturing patient-reported outcomes in dermatology. Br J Dermatol. 2019;181(4):826–7.PubMed
61.
Zurück zum Zitat Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305–14.PubMed Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305–14.PubMed
63.
Zurück zum Zitat Campbell N, Ali F, Finlay AY, Salek SS. Equivalence of electronic and paper-based patient-reported outcome measures. Qual Life Res. 2015;24(8):1949–61.PubMed Campbell N, Ali F, Finlay AY, Salek SS. Equivalence of electronic and paper-based patient-reported outcome measures. Qual Life Res. 2015;24(8):1949–61.PubMed
64.
Zurück zum Zitat Campagna M, Naka F, Lu J. Teledermatology: an updated overview of clinical applications and reimbursement policies. Int J Womens Dermatol. 2017;3(3):176–9.PubMedPubMedCentral Campagna M, Naka F, Lu J. Teledermatology: an updated overview of clinical applications and reimbursement policies. Int J Womens Dermatol. 2017;3(3):176–9.PubMedPubMedCentral
65.
Zurück zum Zitat Flaten HK, St Claire C, Schlager E, Dunnick CA, Dellavalle RP. Growth of mobile applications in dermatology—2017 update. Dermatol Online J. 2018;24(2):13. Flaten HK, St Claire C, Schlager E, Dunnick CA, Dellavalle RP. Growth of mobile applications in dermatology—2017 update. Dermatol Online J. 2018;24(2):13.
66.
Zurück zum Zitat Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, et al. Effectiveness of online vs in-person care for adults with psoriasis: a randomized clinical trial. JAMA Netw Open. 2018;1(6):e183062.PubMedPubMedCentral Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, et al. Effectiveness of online vs in-person care for adults with psoriasis: a randomized clinical trial. JAMA Netw Open. 2018;1(6):e183062.PubMedPubMedCentral
67.
Zurück zum Zitat Squitieri L, Bozic KJ, Pusic AL. The role of patient-reported outcome measures in value-based payment reform. Value Health. 2017;20(6):834–6.PubMedPubMedCentral Squitieri L, Bozic KJ, Pusic AL. The role of patient-reported outcome measures in value-based payment reform. Value Health. 2017;20(6):834–6.PubMedPubMedCentral
68.
Zurück zum Zitat Ehlers AP, Khor S, Cizik AM, Leveque JA, Shonnard NS, Oskouian RJ, et al. Use of patient-reported outcomes and satisfaction for quality assessments. Am J Manag Care. 2017;23(10):618–22.PubMedPubMedCentral Ehlers AP, Khor S, Cizik AM, Leveque JA, Shonnard NS, Oskouian RJ, et al. Use of patient-reported outcomes and satisfaction for quality assessments. Am J Manag Care. 2017;23(10):618–22.PubMedPubMedCentral
69.
Zurück zum Zitat Gensheimer SG, Wu AW, Snyder CF. Oh, the places we’ll go: patient-reported outcomes and electronic health records. Patient. 2018;11(6):591–8.PubMed Gensheimer SG, Wu AW, Snyder CF. Oh, the places we’ll go: patient-reported outcomes and electronic health records. Patient. 2018;11(6):591–8.PubMed
71.
Zurück zum Zitat Secrest AM, Hopkins ZH, Frost ZE, Taliercio VL, Edwards LD, Biber JE, et al. Quality of life assessed using skindex-16 scores among patients with acne receiving isotretinoin treatment. JAMA Dermatol. 2020;156(10):1–9.PubMedCentral Secrest AM, Hopkins ZH, Frost ZE, Taliercio VL, Edwards LD, Biber JE, et al. Quality of life assessed using skindex-16 scores among patients with acne receiving isotretinoin treatment. JAMA Dermatol. 2020;156(10):1–9.PubMedCentral
72.
Zurück zum Zitat Kotter JP, Schlesinger LA. Choosing strategies for change. Harv Bus Rev. 1979;57(2):106–14.PubMed Kotter JP, Schlesinger LA. Choosing strategies for change. Harv Bus Rev. 1979;57(2):106–14.PubMed
73.
Zurück zum Zitat Carlisle RP, Flint ND, Hopkins ZH, Eliason MJ, Duffin KC, Secrest AM. Administrative burden and costs of prior authorizations in a dermatology department. JAMA Dermatol. 2020;156(10):1074–8.PubMed Carlisle RP, Flint ND, Hopkins ZH, Eliason MJ, Duffin KC, Secrest AM. Administrative burden and costs of prior authorizations in a dermatology department. JAMA Dermatol. 2020;156(10):1074–8.PubMed
74.
Zurück zum Zitat Barbieri JS, Gelfand JM. Patient-reported outcome measures as complementary information to clinician-reported outcome measures in patients with psoriasis. JAMA Dermatol. 2021. Barbieri JS, Gelfand JM. Patient-reported outcome measures as complementary information to clinician-reported outcome measures in patients with psoriasis. JAMA Dermatol. 2021.
75.
Zurück zum Zitat Armstrong AW, Ford AR, Chambers CJ, Maverakis E, Dunnick CA, Chren MM, et al. Online care versus in-person care for improving quality of life in psoriasis: a randomized controlled equivalency trial. J Investig Dermatol. 2019;139(5):1037–44.PubMed Armstrong AW, Ford AR, Chambers CJ, Maverakis E, Dunnick CA, Chren MM, et al. Online care versus in-person care for improving quality of life in psoriasis: a randomized controlled equivalency trial. J Investig Dermatol. 2019;139(5):1037–44.PubMed
76.
Zurück zum Zitat Kennedy J, Arey S, Hopkins Z, Tejasvi T, Farah R, Secrest AM, et al. Dermatologist perceptions of teledermatology implementation and future use after COVID-19: demographics, barriers, and insights. JAMA Dermatol. 2021;157(5):595–7.PubMedPubMedCentral Kennedy J, Arey S, Hopkins Z, Tejasvi T, Farah R, Secrest AM, et al. Dermatologist perceptions of teledermatology implementation and future use after COVID-19: demographics, barriers, and insights. JAMA Dermatol. 2021;157(5):595–7.PubMedPubMedCentral
77.
Zurück zum Zitat Hopkins ZH, Han G, Tejasvi T, Deda LC, Goldberg R, Kennedy J, et al. Teledermatology during the COVID-19 pandemic: lessons learned and future directions. Cutis. 2022;109(1):12–3.PubMed Hopkins ZH, Han G, Tejasvi T, Deda LC, Goldberg R, Kennedy J, et al. Teledermatology during the COVID-19 pandemic: lessons learned and future directions. Cutis. 2022;109(1):12–3.PubMed
78.
Zurück zum Zitat Secrest AM, Hess R. Patient-reported outcomes in clinical practice in autoimmune bullous disease patients. J Am Acad Dermatol. 2018;79(3):AB216. Secrest AM, Hess R. Patient-reported outcomes in clinical practice in autoimmune bullous disease patients. J Am Acad Dermatol. 2018;79(3):AB216.
84.
Zurück zum Zitat Brazier JE, Harper R, Jones NMB, O’Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4.PubMedPubMedCentral Brazier JE, Harper R, Jones NMB, O’Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4.PubMedPubMedCentral
85.
Zurück zum Zitat Hunt SM, McEwen J. The development of a subjective health indicator. Sociol Health Ill. 1980;2(3):231–46. Hunt SM, McEwen J. The development of a subjective health indicator. Sociol Health Ill. 1980;2(3):231–46.
86.
Zurück zum Zitat Bushnik T. Nottingham Health Profile. In: Kreutzer JS, DeLuca J, Caplan B, editors. Encyclopedia of Clinical Neuropsychology. New York: Springer; 2011. pp. 1797–8. Bushnik T. Nottingham Health Profile. In: Kreutzer JS, DeLuca J, Caplan B, editors. Encyclopedia of Clinical Neuropsychology. New York: Springer; 2011. pp. 1797–8.
87.
Zurück zum Zitat Ebrahim S, Barer D, Nouri F. Use of the Nottingham Health Profile with patients after a stroke. J Epidemiol Community Health. 1986;40(2):166–9.PubMedPubMedCentral Ebrahim S, Barer D, Nouri F. Use of the Nottingham Health Profile with patients after a stroke. J Epidemiol Community Health. 1986;40(2):166–9.PubMedPubMedCentral
90.
Zurück zum Zitat El Fakir S, Baybay H, Bendahhou K, Obtel M, Benchat L, Mernissi FZ, et al. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco. J Dermatol Treat. 2014;25(2):106–9. El Fakir S, Baybay H, Bendahhou K, Obtel M, Benchat L, Mernissi FZ, et al. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco. J Dermatol Treat. 2014;25(2):106–9.
91.
Zurück zum Zitat Chren M-M, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–40.PubMed Chren M-M, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–40.PubMed
92.
Zurück zum Zitat Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, DeMuro-Mercon C, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res. 1996;5(5):481–90.PubMed Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, DeMuro-Mercon C, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res. 1996;5(5):481–90.PubMed
94.
Zurück zum Zitat Esmann S, Vinding GR, Christensen KB, Jemec GBE. Assessing the influence of actinic keratosis on patients’ quality of life: the AKQoL questionnaire. Br J Dermatol. 2013;168(2):277–83.PubMed Esmann S, Vinding GR, Christensen KB, Jemec GBE. Assessing the influence of actinic keratosis on patients’ quality of life: the AKQoL questionnaire. Br J Dermatol. 2013;168(2):277–83.PubMed
95.
Zurück zum Zitat Weller K, Magerl M, Peveling-Oberhag A, Martus P, Staubach P, Maurer M. The Angioedema Quality of Life Questionnaire (AE-QoL)—assessment of sensitivity to change and minimal clinically important difference. Allergy. 2016;71(8):1203–9.PubMed Weller K, Magerl M, Peveling-Oberhag A, Martus P, Staubach P, Maurer M. The Angioedema Quality of Life Questionnaire (AE-QoL)—assessment of sensitivity to change and minimal clinically important difference. Allergy. 2016;71(8):1203–9.PubMed
96.
Zurück zum Zitat Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy. 2012;67(10):1289–98.PubMed Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy. 2012;67(10):1289–98.PubMed
101.
Zurück zum Zitat Vourc’h-Jourdain M, Barbarot S, Taieb A, Diepgen T, Ambonati M, Durosier V, et al. Patient-Oriented SCORAD: a self-assessment score in atopic dermatitis. Dermatology. 2009;218(3):246–51. Vourc’h-Jourdain M, Barbarot S, Taieb A, Diepgen T, Ambonati M, Durosier V, et al. Patient-Oriented SCORAD: a self-assessment score in atopic dermatitis. Dermatology. 2009;218(3):246–51.
104.
Zurück zum Zitat Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants’ Dermatitis Quality of Life Index. Br J Dermatol. 2001;144(1):104–10.PubMed Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants’ Dermatitis Quality of Life Index. Br J Dermatol. 2001;144(1):104–10.PubMed
107.
Zurück zum Zitat Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope. 2007;117(3):399–405.PubMedPubMedCentral Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope. 2007;117(3):399–405.PubMedPubMedCentral
108.
Zurück zum Zitat Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg. 2006;8(5):314–8.PubMedPubMedCentral Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg. 2006;8(5):314–8.PubMedPubMedCentral
109.
Zurück zum Zitat Vinding GR, Christensen KB, Esmann S, Olesen AB, Jemec GBE. Quality of life in non-melanoma skin cancer—the skin cancer quality of life (SCQoL) questionnaire. Dermatol Surg. 2013;39(12):1784–93.PubMed Vinding GR, Christensen KB, Esmann S, Olesen AB, Jemec GBE. Quality of life in non-melanoma skin cancer—the skin cancer quality of life (SCQoL) questionnaire. Dermatol Surg. 2013;39(12):1784–93.PubMed
110.
Zurück zum Zitat Burdon-Jones D, Gibbons K. The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers. J Eur Acad Dermatol Venereol. 2013;27(9):1109–13.PubMed Burdon-Jones D, Gibbons K. The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers. J Eur Acad Dermatol Venereol. 2013;27(9):1109–13.PubMed
111.
Zurück zum Zitat Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587–93.PubMed Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587–93.PubMed
112.
Zurück zum Zitat Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008;59(2):234–44.PubMed Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008;59(2):234–44.PubMed
113.
Zurück zum Zitat Stumpf A, Pfleiderer B, Fritz F, Osada N, Chen SC, Ständer S. Assessment of quality of life in chronic pruritus: relationship between ItchyQoL and Dermatological Life Quality Index in 1,150 patients. Acta Derm Venereol. 2018;98:142–3.PubMed Stumpf A, Pfleiderer B, Fritz F, Osada N, Chen SC, Ständer S. Assessment of quality of life in chronic pruritus: relationship between ItchyQoL and Dermatological Life Quality Index in 1,150 patients. Acta Derm Venereol. 2018;98:142–3.PubMed
Metadaten
Titel
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology
verfasst von
Ashley M. Snyder
Suephy C. Chen
Mary-Margaret Chren
Laura K. Ferris
LaVar D. Edwards
Robert A. Swerlick
Nicholas D. Flint
Amy M. Cizik
Rachel Hess
Jacob Kean
Aaron M. Secrest
for the Dermatology PRO Consortium
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 4/2023
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-023-00758-8

Weitere Artikel der Ausgabe 4/2023

American Journal of Clinical Dermatology 4/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.